SCHEMBL8788717

SCHEMBL8788717

COc1ccc(CN(C)CCCSc2ccc(NC(=O)c3cccc4c(=O)c5ccccc5[nH]c34)cc2)cc1OC

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 5/20 0.57
▸ ABCB1 P08183 2/20 0.46
▸ AKT1 P31749 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ BCHE P06276 1/20 0.42
▸ ACHE P22303 1/20 0.42
▸ OPRM1 P35372 3/20 0.41
▸ TMEM97 Q5BJF2 3/20 0.41
▸ SIGMAR1 Q99720 3/20 0.41
▸ PARP14 Q460N5 1/20 0.41
▸ OPRK1 P41145 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ TP53 P04637 3/20 0.40
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8789139 0.96 ABCG2 (0.58) ABCG2ABCB1AKT1MAPTMAPK1
SCHEMBL8790357 0.92 ABCG2 (0.54) ABCG2ABCB1MAPTMAPK1SMN1; SMN2
SCHEMBL8789798 0.91 ABCG2 (0.48) ABCG2ABCB1MAPTMAPK1SMN1; SMN2
SCHEMBL8790077 0.90 ABCG2 (0.47) ABCG2ABCB1MAPTMAPK1SMN1; SMN2
SCHEMBL8788454 0.90 ABCG2 (0.64) ABCG2ABCB1AKT1MAPTBCHE
SCHEMBL8789078 0.90 ABCG2 (0.47) ABCG2ABCB1MAPTMAPK1SMN1; SMN2
SCHEMBL8789201 0.89 ABCG2 (0.59) ABCG2ABCB1AKT1MAPTBCHE
SCHEMBL8789989 0.89 ABCG2 (0.63) ABCG2ABCB1AKT1MAPTBCHE
SCHEMBL8789541 0.89 ABCG2 (0.65) ABCG2ABCB1AKT1MAPTBCHE
SCHEMBL8791484 0.89 ABCG2 (0.62) ABCG2ABCB1AKT1MAPTBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569380-B1 ACRIDINE DERIVATIVES GLAXO LAB SA (FR) 1997-05-28 — — EP claimed
US-5604237-A IMPROVE OR INCREASE EFFICACY OF ANTITUMOR AGENT, INCREASE OR RESTORE SENSITIVITY OF TUMOR TO ANTITUMOR AGENT, REVERSE OR REDUCE RESISTANCE OF TUMOR TO ANTITUMOR AGENT LABORATOIRES GLAXO SA (FR) 1997-02-18 — — US claimed
EP-0494623-A1 Acridine derivatives LABORATOIRES GLAXO SA (FR) 1992-07-15 — — EP claimed
EP-0569380-B1 ACRIDINE DERIVATIVES GLAXO LAB SA (FR) 1997-05-28 — — EP disclosed
US-5604237-A IMPROVE OR INCREASE EFFICACY OF ANTITUMOR AGENT, INCREASE OR RESTORE SENSITIVITY OF TUMOR TO ANTITUMOR AGENT, REVERSE OR REDUCE RESISTANCE OF TUMOR TO ANTITUMOR AGENT LABORATOIRES GLAXO SA (FR) 1997-02-18 — — US disclosed
EP-0494623-A1 Acridine derivatives LABORATOIRES GLAXO SA (FR) 1992-07-15 — — EP disclosed
Send feedback